Kinathera Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
Kinathera General Information
Description
Operator of a pharmaceutical company intended to bring a pharmacological therapeutic approach for the treatment of immuno fibrotic autoimmune diseases. The company is developing oral new chemical entities very specific for the inhibition of TBK1 / IKKe in rare immuno-fibrotic diseases such as scleroderma or lupus nephritis with animal proof of concept in therapeutic mode on pulmonary fibrosis and modulation of Type I interferon and autoantibodies, enabling physicians to improve human quality of life.
Contact Information
Website
www.kinathera.com
Formerly Known As
Balmes Transplantation
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
- 163 avenue de Luminy, Luminy Biotech Entreprises
- Bâtiment Béret-Delaage, Case 922
- 13288 Marseille
- France
+33 04 00 00 00 00
Kinathera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 000.00 | Completed | Pre-Clinical Trials | |||
| 7. Seed Round | 09-Aug-2023 | 000.00 | 000.00 | In Progress | Pre-Clinical Trials | |
| 6. Later Stage VC | 13-Jun-2022 | 00000 | 00.000 | Completed | Pre-Clinical Trials | |
| 5. Seed Round | 22-Dec-2017 | 00000 | 00000 | 00.000 | Completed | Pre-Clinical Trials |
| 4. Angel (individual) | 00000 | 00000 | Completed | Startup | ||
| 3. Grant | 00000 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Kinathera Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 |
Kinathera Patents
Kinathera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3095755-A1 | New cytoprotective drugs | Pending | 10-May-2019 | 000000000 | 00 |
| AU-2018366352-A1 | Novel cytoprotective drugs | Inactive | 17-Nov-2017 | 000000000 | |
| CA-3079645-A1 | Novel cytoprotective drugs | Inactive | 17-Nov-2017 | 000000000 | |
| EP-3710038-A1 | Novel cytoprotective drugs | Inactive | 17-Nov-2017 | 000000000 | |
| FR-3073738-A1 | New cytoprotective medicines | Inactive | 17-Nov-2017 | A61K38/12 |
Kinathera Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Patrick Berna Ph.D | Founder, Chief Executive Officer, President & General Manager | ||
| Carole Valenti | Chief Development Officer |
Kinathera Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Kinathera Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Provence Business Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| SeedFolio | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Bpifrance | Sovereign Wealth Fund | 000 0000 | 000000 0 | ||
| EUROBIOMED | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| French Government | Government | 000 0000 | 000000 0 |